Xuerong Wen

Xuerong Wen

University of Rhode Island

H-index: 22

North America-United States

About Xuerong Wen

Xuerong Wen, With an exceptional h-index of 22 and a recent h-index of 17 (since 2020), a distinguished researcher at University of Rhode Island, specializes in the field of Pharmacoepidemiology, Drug Safety.

His recent articles reflect a diverse array of research interests and contributions to the field:

Reducing the risks of prenatal opioid exposure in children

Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis

Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin

Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation

Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study

Prognostic factors of COVID‐19: an umbrella review endorsed by the International Society for Pharmacoepidemiology

Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study

Comparative safety analysis of opioid agonist treatment in pregnant women with opioid use disorder: a population-based study

Xuerong Wen Information

University

Position

___

Citations(all)

1590

Citations(since 2020)

898

Cited By

935

hIndex(all)

22

hIndex(since 2020)

17

i10Index(all)

38

i10Index(since 2020)

28

Email

University Profile Page

Google Scholar

Xuerong Wen Skills & Research Interests

Pharmacoepidemiology

Drug Safety

Top articles of Xuerong Wen

Reducing the risks of prenatal opioid exposure in children

2024/4/24

Xuerong Wen
Xuerong Wen

H-Index: 14

Stephen Kogut
Stephen Kogut

H-Index: 10

Prenatal Exposure to Opioids and Neurodevelopmental Disorders in Children: A Bayesian Mediation Analysis

American Journal of Epidemiology

2024/2

Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin

Research and Practice in Thrombosis and Haemostasis

2024/1/1

Yichi Zhang
Yichi Zhang

H-Index: 2

Xuerong Wen
Xuerong Wen

H-Index: 14

Role of standard HLA mismatch in modifying associations between non-pharmacologic risk factors and solid organ malignancy after kidney transplantation

Transplant Immunology

2023/10/1

Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications: A Retrospective Cohort Study

Neurology

2023/9/5

Xuerong Wen
Xuerong Wen

H-Index: 14

Prognostic factors of COVID‐19: an umbrella review endorsed by the International Society for Pharmacoepidemiology

2023/9

Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study

Clinical and Translational Science

2023/6

Comparative safety analysis of opioid agonist treatment in pregnant women with opioid use disorder: a population-based study

Drug safety

2023/3

A Bayesian latent class model for predicting gestational age in health administrative data

Pharmaceutical statistics

2022/11

Shuang Wang
Shuang Wang

H-Index: 1

Xuerong Wen
Xuerong Wen

H-Index: 14

ISPE‐Endorsed Guidance in Using Electronic Health Records for Comparative Effectiveness Research in COVID‐19: Opportunities and Trade‐Offs

Clinical Pharmacology & Therapeutics

2022/11

Machine learning for improving high‐dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature

2022/9

Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision …

2022/4/1

Hongbo Yuan
Hongbo Yuan

H-Index: 10

Xuerong Wen
Xuerong Wen

H-Index: 14

Addressing posttreatment selection bias in comparative effectiveness research, using real-world data and simulation

American journal of epidemiology

2022/2

Circulating endothelial cells as predictor of long‐term mortality and adverse cardiovascular outcomes in hemodialysis patients

Seminars in Dialysis

2021/3

Initial patterns of prescription opioid supply and risk of mortality among insured adults in the United States

Journal of addiction medicine

2021/3/1

Joseph W Hogan
Joseph W Hogan

H-Index: 32

Xuerong Wen
Xuerong Wen

H-Index: 14

Maternal complications and prescription opioid exposure during pregnancy: using marginal structural models

Drug safety

2021/12

Xuerong Wen
Xuerong Wen

H-Index: 14

Shuang Wang
Shuang Wang

H-Index: 1

Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms

Acta Pharmaceutica Sinica B

2021/12/1

Xuerong Wen
Xuerong Wen

H-Index: 14

Stephen Kogut
Stephen Kogut

H-Index: 10

Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)

Plos one

2021/9/15

Association between prenatal opioid exposure and neurodevelopmental outcomes in early childhood: a retrospective cohort study

Drug safety

2021/8

Xuerong Wen
Xuerong Wen

H-Index: 14

Shuang Wang
Shuang Wang

H-Index: 1

Comparative effectiveness and safety of prasugrel versus ticagrelor following percutaneous coronary intervention: An observational study

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

2021/6

See List of Professors in Xuerong Wen University(University of Rhode Island)